title: Reply: To PMID 24457977.
authors: *Department of Ophthalmology, Rush University Medical Center, Chicago, Illinois †Illinois Retina Associates, SC, Chicago, Illinois.
authors: Kevin
authors: K
authors: Ferenchak
authors: Mathew W
authors: MW
authors: MacCumber
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D003930:Diabetic Retinopathy / Q000601:surgery*; D005260:Female; D006801:Humans; D008297:Male; D019106:Postoperative Hemorrhage / Q000188:drug therapy*; D014821:Vitrectomy / Q000009:adverse effects*; D014823:Vitreous Hemorrhage / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized